Literature DB >> 32569569

The history of renal transplantation in Canada: A urologic perspective.

Max Alexander Levine1, Joseph L Chin2, Andrew Rasmussen1, Alp Sener1, Patrick P Luke1.   

Abstract

While the urologist's involvement in kidney transplantation varies from center to center and country to country, urologists remain integral to many programs across Canada. From the early days of kidney transplant to contemporary times, the leadership, vision, and skillset of Canadian urologists have helped progress the field. In this review of Canadian urologists' role in kidney transplantation, the achievements of this professional group are highlighted and celebrated. Original contributors to the field, as well as notable achievements are highlighted, with a focus on the impact of Canadian urologists.

Year:  2020        PMID: 32569569      PMCID: PMC7704082          DOI: 10.5489/cuaj.6744

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  62 in total

1.  Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation.

Authors:  Yves Caumartin; Jancy Stephen; Jian P Deng; Dameng Lian; Zhu Lan; Weihua Liu; Bertha Garcia; Anthony M Jevnikar; Hao Wang; Gediminas Cepinskas; Patrick P W Luke
Journal:  Kidney Int       Date:  2011-01-26       Impact factor: 10.612

2.  Alteration in CD45RBhi/CD45RBlo T-cell ratio following CD45RB monoclonal-antibody therapy occurs by selective deletion of CD45RBhi effector cells.

Authors:  Patrick P W Luke; Jian P Deng; Catherine A O'Brien; Michelle Everest; Anne V Hall; Subrata Chakrabarti; Peta J O'Connell; Robert Zhong; Anthony M Jevnikar
Journal:  Transplantation       Date:  2003-07-27       Impact factor: 4.939

3.  Therapy for mouse renal allograft rejection by monoclonal antibody to CD45RB.

Authors:  A I Lazarovits; S Poppema; Z Zhang; M Khandaker; C E Le Feuvre; S K Singhal; B M Garcia; N Ogasa; A M Jevnikar; M J White; G Singh; C R Stiller; R Z Zhong
Journal:  Transplant Proc       Date:  1996-12       Impact factor: 1.066

4.  Update for the Canadian multicentre trial of cyclosporine in renal allografts.

Authors:  C R Stiller
Journal:  N Engl J Med       Date:  1984-05-31       Impact factor: 91.245

Review 5.  Transplanting kidneys from donors with small renal masses - a strategy to expand the donor pool.

Authors:  Octav Cristea; Jeff Warren; Brian Blew; Neal Rowe
Journal:  Can Urol Assoc J       Date:  2019-07-23       Impact factor: 1.862

6.  Is routine ureteric stenting needed in kidney transplantation? A randomized trial.

Authors:  J Dominguez; C M Clase; K Mahalati; A S MacDonald; V C McAlister; P Belitsky; B Kiberd; J G Lawen
Journal:  Transplantation       Date:  2000-08-27       Impact factor: 4.939

7.  Fate of renal allografts transplanted in patients with urinary diversion.

Authors:  D A Hatch; P Belitsky; J M Barry; A C Novick; R J Taylor; M L Jordan; A I Sagalowsky; M R Zaontz
Journal:  Transplantation       Date:  1993-10       Impact factor: 4.939

8.  Detrimental effects of prolonged warm renal ischaemia-reperfusion injury are abrogated by supplemental hydrogen sulphide: an analysis using real-time intravital microscopy and polymerase chain reaction.

Authors:  Justin X G Zhu; Melanie Kalbfleisch; Yi Xin Yang; Relka Bihari; Ian Lobb; Michael Davison; Amy Mok; Gedaminas Cepinskas; Abdel-Rahman Lawendy; Alp Sener
Journal:  BJU Int       Date:  2012-10-09       Impact factor: 5.588

9.  Long-term follow-up of pediatric en bloc renal transplantation.

Authors:  K A Beasley; F Balbontin; A Cook; M Bloch; V C McAlister; J Lawen; P P W Luke
Journal:  Transplant Proc       Date:  2003-11       Impact factor: 1.066

10.  Extracorporeal renal surgery and autotransplantation: indications, techniques and results.

Authors:  A C Novick; B H Stewart; R A Straffon
Journal:  J Urol       Date:  1980-06       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.